A multi-centre phase I/II proof-of-concept clinical trial exploring the effects of early intensive antiretroviral therapy (ART) on achieving HIV remission in neonates. Started in June 2015 at Baylor-Ugandaâs Centre of Excellence HIV clinic in Mulago, this ongoing study will also assess the safety and pharmacokinetics of early intensive ART in neonates